PharmaBoardroom

Interview: Carla Benedito – General Manager, Shire Portugal

Carla Benedito, general manager of Shire Portugal, provides useful insight into the rare diseases landscape in Portugal. Carla discusses market access…

Interview: Gary Hendler – Chairman & CEO, Eisai EMEA

Confirming Eisai’s commitment to keeping its EMEA headquarters in the UK, Gary Hendler, chairman and CEO EMEA, and Nick Burgin, COO and president of…

Interview: David Valenzia – Territory Senior Partner, PwC…

David Valenzia, territory senior partner at PwC Malta, gives his insights on the evolution of the healthcare industry in Malta as well as the key role…

Interview: Carlos Teixeira – CEO, Teva Spain &…

Carlos Teixeira, CEO of Teva Spain and Portugal, discusses the challenges the generic sector is facing in Spain, which ultimately spurred the company…

Top Pharma R&D Spenders in Europe Ranking

The top spenders on pharma R&D in Europe for 2015 were Switzerland - which spent over EUR 6.5 billion - followed by Germany - which spent EUR 6.2…

The Cannabis Companies Behaving Like Biotechs

While many Canadian medical cannabis outfits cover the entire value chain, from research and development through to manufacturing and distribution,…

Reinier Schlatmann – CEO, Philips Central and Eastern…

Reinier Schlatmann, Philips CEO in Central and Eastern Europe, talks about the strategic significance of Poland for the company and how the…

The Four Top Tech Disruptions in Pharma

In May 2018, PharmaBoardroom’s readers were asked what they felt were the biggest new sources of disruption to the traditional pharma industry…

Interview: Eva Prada – Director, British Chamber of…

Eva Prada, director of the British Chamber of Commerce in Spain, discusses trade relations between the UK and Spain and the activities of the Chamber…